As FSU emerges as the No. 11 Top Public University in America in 2026, Early Action applications grow increasingly ...

International Breema Week 2026: Participate and explore the practice of Breema and self-Breema with online and in-person ...

New name reflects the Company's strategic evolution focused on later-stage preclinical assets leveraging its most advanced, signature gene-editing capabilities Pre-IND meeting held in 4Q 2025 followin ...

The right combination of a learning-focused device and curriculum-aligned digital content can significantly impact a child's ...

New options for testing and treating some of the most common sexually transmitted diseases are becoming available. In the ...

Fourth quarter 2025 revenue of approximately $13.2 million, Up 60% Year-Over-YearFull-year 2025 revenue growth of approximately 53% exceeded 2025 guidanceSet initial 2026 revenue guidance of ...

Interested in tapping maple trees? Maybe you'd like to try your hand at writing or making grain art? Find an activity the ...

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today ...

Tamboran Resources Corporation Chairman, Richard Stoneburner, said: "Todd brings over two decades of upstream experience with a strong record of operational leadership, capital discipline, safety and ...

The festival saw a record 25,000 attendees, over 60 speakers, and 30+ interactive exhibits and workshops, making it one of ...

CASGEVY® launch acceleration continues, supporting multi-billion-dollar potential- -Broad pipeline supported by leading ...

CBeyondTM Phase 2a 26-week extension data update and interim results expected Q1 2026. CBeyond Phase 2a Data Monitoring ...